1GA
RMD icon

1st Global Advisors’s ResMed RMD Stock Holding History

1st Global Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-7,618
Closed -$402K – 422
2013
Q3 		$402K Buy
7,618
+1,178
+18% +$57.1K 0.08% 191
2013
Q2 		$291K Buy
+6,440
New +$306K 0.06% 233

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

1st Global Advisors's RMD Position: Q4 2013 in Review

1st Global Advisors sold out of ResMed (RMD) in Q4 2013, closing a stake of 7,618 shares — an estimated $402K sold.

1st Global Advisors first reported a position in RMD in Q2 2013 and held it in 2 quarters. The position peaked at $402K in Q3 2013. 328 funds tracked by Wall St. Rank hold RMD as of Q4 2013.

  • 1st Global Advisors reported no remaining ResMed position as of Q4 2013 after selling out during the quarter.
  • 1st Global Advisors sold 7,618 ResMed shares in Q4 2013, an estimated $402K.
  • 1st Global Advisors first reported a position in ResMed in Q2 2013 and held it in 2 quarters.
  • 1st Global Advisors's ResMed position peaked at $402K in Q3 2013.
  • 328 funds tracked by Wall St. Rank held ResMed as of Q4 2013.

Based on 1st Global Advisors's 13F filing for Q4 2013, filed 14 Jan 2014.